Skip to main content

Want a detailed portfolio tracker?

Tourmaline Bio (TRML) P/E (2024 - 2026)

Tourmaline Bio (TRML) P/E from Apr 1, 2024 to Jul 21, 2026. The TTM Tourmaline Bio (TRML) P/E is -13.90. You can export chart.

P/E

Annual P/E change of Tourmaline Bio (TRML)

YearP/EChange
2026-13.90N/A
2025-13.90+98.33%
2024-7.01N/A

Comparison Tourmaline Bio (TRML) P/E with competitors

Tourmaline Bio (TRML) P/E is -13.90.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.01%
NBYStablecoin Development Corp0.00-100.03%
ENLVEnlivex Ltd0.07-100.54%
FGENFibroGen Inc0.24-101.73%
CHRSCoherus Biosciences Inc0.85-106.10%
FBIOFortress Biotech Inc0.95-106.83%
ORMPOramed Pharmaceuticals Inc1.50-110.81%
AGENAgenus Inc3.01-121.64%
INVAInnoviva Inc3.15-122.68%
VXRTVaxart Inc3.55-125.53%
CRMDCorMedix Inc3.63-126.09%
CVACCureVac N.V.4.45-131.97%
GLPGGalapagos NV4.86-134.94%
SRPTSarepta Therapeutics Inc4.88-135.11%
ABEOAbeona Therapeutics Inc5.39-138.75%
ABUSArbutus Biopharma Corp5.60-140.24%
ZVRAZevra Therapeutics Inc5.89-142.34%
SPROSpero Therapeutics Inc6.23-144.79%
CGENCompugen Ltd6.31-145.41%
RIGLRigel Pharmaceuticals6.87-149.42%
SLXNSilexion Therapeutics Corp7.30-152.47%
OMEROmeros Corporation9.26-166.59%
AUPHAurinia Pharmaceuticals Inc9.58-168.93%
PLXProtalix BioTherapeutics Inc10.89-178.33%
ACADAcadia Pharmaceuticals Inc11.73-184.35%
TBPHTheravance Biopharma Inc12.26-188.19%
ADMAAdma Biologics Inc12.42-189.31%
HRMYHarmony Biosciences Holdings Inc13.82-199.39%
SABSSAB Biotherapeutics Inc14.14-201.66%
NAGENiagen Bioscience Inc14.82-206.57%
INCYIncyte Corp15.82-213.79%
REGNRegeneron Pharmaceuticals Inc15.86-214.04%
PBYIPuma Biotechnology Inc17.32-224.53%
CPRXCatalyst Pharmaceuticals Inc17.44-225.42%
EXELExelixis Inc17.54-226.13%
TGTXTG Therapeutics Inc18.97-236.40%
MDXGMimedx Group Inc20.55-247.81%
XOMAXOMA Royalty Corp22.87-264.51%
ARGXArgen X SE24.30-274.75%
CTMXCytomX Therapeutics Inc24.82-278.51%
XOMAOXOMA Royalty Corp25.34-282.28%
HALOHalozyme Therapeutics Inc25.62-284.29%
XOMAPXOMA Royalty Corp25.67-284.62%
VRTXVertex Pharmaceuticals Inc27.99-301.34%
RPRXRoyalty Pharma plc - Class A28.69-306.32%
SLNOSoleno Therapeutics Inc29.02-308.68%
ASNDAscendis Pharma A/S30.09-316.37%
LGNDLigand Pharmaceuticals Inc - Class B37.91-372.66%
APLSApellis Pharmaceuticals Inc39.02-380.64%
BMRNBiomarin Pharmaceutical Inc42.21-403.59%
KRYSKrystal Biotech Inc45.34-426.11%
ONCBeiGene Ltd69.54-600.13%
PHARPharming Group N.V.75.03-639.58%
TECHBio-Techne Corp101.96-833.28%
VCELVericel Corp109.92-890.55%
ALNYAlnylam Pharmaceuticals Inc117.96-948.40%
GMABGenmab140.29-1108.97%
TLXTelix Pharmaceuticals Ltd162.15-1266.20%
CORTCorcept Therapeutics Inc212.86-1630.87%